F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
Based on observations, review of facility policy and clinical records and staff interview, it was determined
that the facility failed to assess a resident for self-administration of medications for one of 12 residents
reviewed (Resident R19).
Residents Affected - Few
Findings include:
Review of facility policy entitled Self-Administration of Medications dated 1/10/25, revealed that Residents
have the right to self-administer medications if the interdisciplinary team has determined that it is clinically
appropriate and safe for the resident to do so. Staff and practitioner will assess each resident's mental and
physical abilities to determine whether self-administering medications is clinically appropriate for the
resident. Staff and practitioner will perform a more specific skill assessment, including (but not limited to)
the resident's: Ability to read and understand medication labels; Comprehension of the purpose and proper
dosage and administration time for his/her medications; Ability to remove medications from a container and
to ingest and swallow (or otherwise administer) the medication; Ability to recognize risks and major adverse
consequences of his/her medications. The staff and practitioner will document their findings and the
choices of residents who are able to self-administer medications. Self-administered medications must be
stored in a safe and secure place, which is not accessible by other residents. The staff and practitioner will
periodically (for example, during quarterly MDS reviews) reevaluate a resident's ability to continue to
self-administer medications.
Resident R19's clinical record revealed an admission date of 11/01/19, with diagnoses that included
Anxiety (a condition that causes a person to be nervous, uneasy, or worried about something or someone),
Asthma (a condition that causes a person's airway to become inflamed, narrow, swell and make it difficult
for a person to breath), and muscular dystrophy (a genetic disease that causes progressive weakness and
loss of muscle mass).
Observations on 2/18/25, at 2:40 p.m., on 2/19/25, at 9:48 a.m. and again on 2/20/25, at 12:15 p.m.
revealed Resident R19 with a Ventolin HFA Inhalation Aerosol Solution (inhaler medication to treat asthma)
on the bedside tray table.
During an interview with Resident R19 on 2/18/25 at 9:48 a.m. he/she stated I always have my inhaler on
my bedside table, I just tell the nurse if I have used it. During an interview with Resident R19 on 2/19/25, at
9:48 a.m. he/she stated I haven't used my inhaler in a long time, maybe a few months.
Resident R19's clinical record revealed a physician's order dated 11/10/23, for Ventolin HFA Inhalation
Aerosol Solution 108 MCG [micrograms]/ACT 2 puffs inhale orally every 4 hours as needed for SOB
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
395877
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395877
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland View Rehabilitation & Healthcare Center
90 Main Street
Brockway, PA 15824
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
[shortness of breath]/wheezing. Resident R19's clinical record lacked a self-administration of medication
assessment or a physician's order to keep the Ventolin Inhaler at the bedside.
During an interview on 2/20/25 at 12:15 p.m. the Nursing Home Administrator confirmed that Resident
R19's Ventolin Inhaler was on his/her bedside table and that his/her clinical record lacked a
self-administration assessment of medication and self-administration order.
28 Pa. Code 211.5(f)(i)(ii)(iii) Medical records
28 Pa. Code 211.12(d)(1)(5) Nursing services
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395877
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395877
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Highland View Rehabilitation & Healthcare Center
90 Main Street
Brockway, PA 15824
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, review of drug manufacturer instructions, and staff interviews, it was determined that
the facility failed to appropriately date and store medications in one of one medication storage rooms.
Findings include:
Observation on 2/18/25, at 1:15 p.m. in the medication storage room, revealed an opened vial of Purified
Protein Derivative (PPD-a skin testing agent for tuberculosis) without an opened date marked on the vial.
A review of the drug manufacturer leaflet indicated a vial of Tubersol which has been entered and in use for
30 days should be discarded.
At the time of the observation, Licensed Practical Nurse Employee E1 confirmed the PPD vial was opened,
undated and not dated to indicate when the medication should be discarded. The Director of Nursing
confirmed on 2/18/25, at 2:37 p.m. the PPD vial should have been noted with an opened date to indicate
after 30 days of use, the vial would be discarded.
28 Pa. Code 211.9(a)(1) Pharmacy services
28 Pa. Code 211.12(d)(1)(5) Nursing services
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395877
If continuation sheet
Page 3 of 3